Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, especially for cancers where procedure possibilities remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/chainlink-technical-analysis-report-21-february-2025/